SYNAPTIXBIO LTD
Company number 13318389 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£13,122,480
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-04-07
- Employees
- 5 (2025 accounts · was 3 in 2024)
- Registered office
- 9400 Garsington Road, Oxford Business Park, Oxford, United Kingdom, OX4 2HN
- Postcode
- OX4 2HN
- Capital
- 637 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-04-06
- Next due by
- 2027-04-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current
Contact details
- Website
- synaptixbio.com
SynaptixBio is a rare disease biotech pioneering ground-breaking development for treatment of severe leukodystrophies which affect the brain. SynaptixBio will tackle a specific acute subset of leukodystrophies by altering the expression of a mutated gene identified as causing the disease.
Among its peers
Top 10%
by shareholders' funds, of 179 similar companies in OX
Trading since 2021.
No.16 of the largest research and experimental development on biotechnology companies in Oxford →
Competitors Oxford
This company ranks 16 among research and experimental development on biotechnology in Oxford.